Sharing Good Homework

If you love actionable ideas in a no-nonsense environment, then our Members inside the services are consistent in identifying great ideas which I then share with the group. 

Headed into 2017, one such idea could easily be a resurgence in the pharma/healthcare space. Should that materialize, it is hard not to like a mid-cap drug play like Aerie, below on the daily chart. Several Members have noted this one, which presents at a conference tonight after the bell, to boot. 

It should be obvious that AERI is a much better technical spot than, say, VRX. We want to seek out relative strength names in healthcare so that they may benefit the most into a sector renaissance next week.

And AERI seems to fit that bill, with price basing well in the context of an established uptrend.